title: Tocilizumab for systemic sclerosis: implications for future trials.
authors.affiliation: Division of Rheumatology, University Hospital Zurich, Switzerland. Electronic address: oliver.distler@usz.ch.
authors.forename: Oliver
authors.initials: O
authors.lastname: Distler
authors.affiliation: Department of Internal Medicine, University of Erlangen-Nuremberg, Germany; Institute for Clinical Immunology, University of Erlangen-Nuremberg, Germany.
authors.forename: Jörg H W
authors.initials: JHW
authors.lastname: Distler
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D061067:Antibodies, Monoclonal, Humanized